BioNTech Investor
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Investors
.jpeg)
.jpeg)
Technology:
CAR-T, CAR-T therapy, Cell_Therapies, RNA
Industry:
AI, Public
Headquarters:
Mainz, Rheinland-Pfalz, Germany
Founded Date:
2008-01-01
Employees Number:
1001-5000
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
3
Acquisitions Number:
Made Acquisitions
Investors Number:
16
Total Funding:
1141164024
Estimated Revenue:
$100M to $500M
Last Funding Date:
2022-04-14
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership